| Dave Lashmet over at Stansberry Venture Technology has a new ad out for his pricey service, and in it he talks up what he says is the "most valuable pill in development, anywhere" -- and guarantees that it will double in the next year and a half (or maybe the next month or two, if all goes well). So what's this mysterious biotech stock? Does it belong in your portfolio? Just click below to... |
